{"transactions":[{"id":4639760,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":184314,"kind":"person","name":"Bisson Sabine","position":1,"cik":"0002152874","reported_name":"Bisson Sabine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Series B Convertible Preferred Stock","published_at":"2026-10-13T22:11:18.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":false,"shares":2504,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2504},"source":{"system":"sec-edgar","filing":"0001213900-26-109156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/2152874/000121390026109156/ownership.xml","form_type":"4"}},{"id":4639759,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":184314,"kind":"person","name":"Bisson Sabine","position":1,"cik":"0002152874","reported_name":"Bisson Sabine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Series A Convertible Preferred Stock","published_at":"2026-10-13T22:11:18.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":false,"shares":1611,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1611},"source":{"system":"sec-edgar","filing":"0001213900-26-109156","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2152874/000121390026109156/ownership.xml","form_type":"4"}},{"id":4639758,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":184314,"kind":"person","name":"Bisson Sabine","position":1,"cik":"0002152874","reported_name":"Bisson Sabine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-10-13T22:11:18.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":true,"shares":2504,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Convertible Preferred Stock (the \"Series B Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock had no expiration date."}],"balance_after":4115,"source":{"system":"sec-edgar","filing":"0001213900-26-109156","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2152874/000121390026109156/ownership.xml","form_type":"4"}},{"id":4639757,"issuer":{"id":184313,"kind":"organization","name":"Retension Pharmaceuticals, Inc.","symbol":"RTSN"},"owners":[{"id":184314,"kind":"person","name":"Bisson Sabine","position":1,"cik":"0002152874","reported_name":"Bisson Sabine","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Common Stock","published_at":"2026-10-13T22:11:18.000Z","date":"2026-10-13","kind":"exercise","planned":false,"acquired":true,"shares":1611,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Convertible Preferred Stock (the \"Series A Preferred Stock\") converted automatically into one share of Common Stock immediately prior to the closing of the Issuer's initial public offering without payment of consideration. The Series A Preferred Stock had no expiration date."}],"balance_after":1611,"source":{"system":"sec-edgar","filing":"0001213900-26-109156","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2152874/000121390026109156/ownership.xml","form_type":"4"}}]}